Notice for eflornithine (Norgine Pty Ltd)
Active ingredients
eflornithine
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
uncoated tablet
Indication
Treatment of neuroblastoma
Therapeutic area
Oncology